Participation in Cytochrome b5 in Anesthetic Metabolism

细胞色素 b5 参与麻醉代谢

• 批准号: 7756760
• 负责人: LUCY A WASKELL
• 金额: $ 30.79万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 1985
• 资助国家: 美国
• 起止时间: 1985-07-01 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7756760
• 关键词: Active Sites; Affect; Anabolism; Anesthetics; Animals; Bacteria; Bile Acids; Binding; Biochemical; Biochemistry; Biodegradation; Carcinogens; Cardiovascular system; Catalysis; Chemicals; Cholesterol; Clinical; Complex; Cytochrome P450; Cytochrome P450 3A4; Cytochromes b5; Development; Drug Interactions; Drug usage; Eicosanoids; Electron Nuclear Double Resonance; Electron Spin Resonance Spectroscopy; Electronics; Electrons; Electrostatics; Employee Strikes; Engineering; Environmental Pollution; Estrogens; Foundations; Freezing; Genetically Engineered Mouse; Goals; Heme; Heme Iron; Histidine; Human; Human Activities; Hydrocortisone; In Vitro; Isoenzymes; Knowledge; Laboratories; Life; Lipids; Liver; Malignant neoplasm of prostate; Mechanics; Mediating; Metabolism; Methods; Modeling; Modification; Molecular; Mothers; Mus; Mutation; Nature; Organ; Organism; Oxidases; Oxidation-Reduction; Oxidoreductase; Oxygen; Pathway interactions; Pharmaceutical Preparations; Phenylalanine; Physiological Processes; Plants; Polychlorinated Biphenyls; Procedures; Prodrugs; Property; Proteins; Protons; Psychotropic Drugs; Public Health; Reaction; Regulation; Relative (related person); Reporting; Research Personnel; Role; Route; Series; Social Welfare; Steroids; Structure; Surface; Testosterone; Therapeutic Agents; Toxic effect; Vitamin D; Xenobiotics; base; bisphenol A; chemical reaction; chemotherapeutic agent; cytochrome b5 reductase; design; environmental agent; human tissue; in vitro activity; in vivo; member; mutant; novel; oxidation; phthalates; prevent; protonation; public health relevance; research study; testosterone biosynthesis; therapeutic target; tool

DESCRIPTION (provided by applicant): The cytochromes P450 (cyts P450) are a ubiquitous superfamily of oxidases whose activity is influenced by a second protein, cytochrome b5 (cyt b5). The long-term goal of this project is to understand the structural and mechanistic basis of the modification of human cyt P450-mediated metabolism by cyt b5 in order to develop and employ strategies to modify the activity of these essential isozymes for human benefit. In order to understand the molecular mechanism by which cyt b5 influences oxidation by cyt P450 in vivo, one must understand the details of how cyt b5 interacts with cyt P450 and how it modifies the catalytic cycle of cyt P450 relative to cyt P450 reductase. There are more than 8,000 members of the cyts P450 superfamily. They are found in all kingdoms of living organisms and plants and are referred to as Mother Nature's blowtorch, due to their ability to oxidize a vast number of stable chemical entities. Humans possess 56 different cyts P450, many of which are essential for early development and life itself. Other human cyts P450 determine the toxicity, duration of action, and elimination of the vast majority of therapeutic agents, carcinogens, and environmental agents to which humans are exposed. Xenobiotic metabolizing cyts P450 are also responsible for the majority of drug-drug interactions and adverse drug reactions. A third group of cyts P450 are responsible for the biosynthesis or metabolism of essential endogenous compounds. This includes virtually all steroids (cholesterol, bile acids, estrogens, testosterone, cortisol, and vitamin D) and many lipids and eicosanoids. Cyts P450 exist in virtually every organ and tissue of humans. A second protein, cyt b5, modulates the biochemical mechanism and activity of selected cyts P450 in humans as well as animals. In fact, cyt b5 is essential for testosterone biosynthesis by a cyt P450 that is currently a therapeutic target for the treatment of prostate cancer. The knowledge gained from the proposed experiments will serve as the foundation for understanding the in vivo regulation of the catalytic mechanism of cyt P450. Although the cyt P450 interaction with cyt b5 has been intensely studied, significant gaps in our knowledge exist. The findings of the planned biochemical and structural experiments will also significantly enhance our ability to predict and eventually modify the routes of metabolism of a large number of environmental contaminants such as phthalates, bisphenol A, polychlorinated biphenyl (PCBs), and a vast number of currently used drugs, including chemotherapeutic agents, psychoactive compounds, and cardiovascular therapies. Knowledge of the molecular mechanism by which the activity of human cyts P450 can be modulated will also prove to be a tremendous asset in developing drugs and procedures to alter the large number of critical physiologic processes in which the 56 human cyts P450 participate. The results of the proposed studies will prove to be extremely valuable in designing less toxic and more specific therapeutic agents and prodrugs, especially chemotherapeutic agents and environmental contaminants. PUBLIC HEALTH RELEVANCE: The proposed studies on how the activity of three of the most important human drug metabolizing cytochromes P450 is affected by a second protein, cytochrome b5, will provide significant new information, not readily available by any others means, about how the activity of human cytochromes P450 is regulated. The proposed studies will also provide a better understanding of the structure and function of, not only drug metabolizing cytochromes P450, but also of cytochromes P450 that are important in the metabolism of endogenous compounds such as testosterone, estrogens, and eicosanoids. This information about the chemical reactivity of human cyts P450 in the presence of its different redox partners will facilitate the design and development of new drugs and enhance the ability of investigators to genetically engineer cyts P450 in bacteria and other organisms to produce compounds to enhance human welfare.

描述（由申请人提供）：细胞色素P450（cyts P450）是一种普遍存在的氧化酶超家族，其活性受第二种蛋白质细胞色素b5（cyt b5）的影响。该项目的长期目标是了解由cyt b5修饰人cyt P450介导的代谢的结构和机制基础，以开发和采用策略来修饰这些必需同工酶的活性以造福人类。为了了解cyt b5影响cyt P450体内氧化的分子机制，必须了解cyt b5如何与cyt P450相互作用以及它如何改变cyt P450相对于cyt P450还原酶的催化循环的细节。CYTS P450超家族有8,000多个成员。它们存在于所有的生物体和植物中，被称为大自然的喷灯，因为它们能够氧化大量稳定的化学实体。人类拥有56种不同的细胞色素P450，其中许多对早期发育和生命本身至关重要。其他人类细胞P450决定毒性，作用持续时间，以及人类暴露的绝大多数治疗剂，致癌物和环境因子的消除。异源生物质代谢细胞P450也是大多数药物相互作用和药物不良反应的原因。第三组细胞P450负责必需内源性化合物的生物合成或代谢。这包括几乎所有的类固醇（胆固醇，胆汁酸，雌激素，睾酮，皮质醇和维生素D）和许多脂质和类花生酸。细胞色素P450几乎存在于人类的每个器官和组织中。第二种蛋白质cyt b5调节人类和动物中选定的细胞色素P450的生化机制和活性。事实上，细胞色素b5是睾酮生物合成所必需的细胞色素P450是目前治疗前列腺癌的治疗靶点。从所提出的实验中获得的知识将作为理解细胞色素P450的催化机制的体内调节的基础。虽然细胞色素P450与细胞色素B5的相互作用已经被深入研究，但我们的知识存在重大空白。计划中的生化和结构实验的结果也将大大提高我们预测和最终修改大量环境污染物的代谢途径的能力，如邻苯二甲酸酯，双酚A，多氯联苯（PCB），以及大量目前使用的药物，包括化疗药物，精神活性化合物和心血管治疗。人类细胞P450的活性可以被调节的分子机制的知识也将被证明是一个巨大的资产，在开发药物和程序，以改变大量的关键生理过程中，56人细胞P450参与。所提出的研究的结果将被证明是非常有价值的，在设计毒性更小，更具体的治疗剂和前药，特别是化疗药物和环境污染物。 公共卫生相关性：关于三种最重要的人类药物代谢细胞色素P450的活性如何受到第二种蛋白质细胞色素b5影响的拟议研究将提供关于人类细胞色素P450活性如何调节的重要新信息，这些信息不容易通过任何其他手段获得。拟议的研究还将提供更好的理解的结构和功能，不仅药物代谢细胞色素P450，而且细胞色素P450是重要的内源性化合物，如睾酮，雌激素和类花生酸的代谢。关于人类细胞P450在其不同氧化还原伙伴存在下的化学反应性的信息将促进新药的设计和开发，并提高研究人员在细菌和其他生物体中对细胞P450进行遗传工程改造以产生化合物以提高人类福利的能力。